An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients
Trédaniel, J., Becht, C., Bekradda, M., De Cremoux, H., Alexandre, J., Chomy, F., Szyldergemajn, S., Yataghene, Y., Culine, S.Volume:
63
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2008.05.028
Date:
February, 2009
File:
PDF, 171 KB
english, 2009